273 related articles for article (PubMed ID: 26604030)
41. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
42. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
[TBL] [Abstract][Full Text] [Related]
43. Microbial Agents as Putative Inducers of B Cell Lymphoma in Sjögren's Syndrome through an Impaired Epigenetic Control: The State-of-The-Art.
Talotta R; Sarzi-Puttini P; Atzeni F
J Immunol Res; 2019; 2019():8567364. PubMed ID: 30723750
[TBL] [Abstract][Full Text] [Related]
44. MYC deregulation in lymphoid tumors: molecular mechanisms, clinical consequences and therapeutic implications.
Sewastianik T; Prochorec-Sobieszek M; Chapuy B; Juszczyński P
Biochim Biophys Acta; 2014 Dec; 1846(2):457-67. PubMed ID: 25199984
[TBL] [Abstract][Full Text] [Related]
45. Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques.
Petrovic J; Zhou Y; Fasolino M; Goldman N; Schwartz GW; Mumbach MR; Nguyen SC; Rome KS; Sela Y; Zapataro Z; Blacklow SC; Kruhlak MJ; Shi J; Aster JC; Joyce EF; Little SC; Vahedi G; Pear WS; Faryabi RB
Mol Cell; 2019 Mar; 73(6):1174-1190.e12. PubMed ID: 30745086
[TBL] [Abstract][Full Text] [Related]
46. Altering chromatin methylation patterns and the transcriptional network involved in regulation of hematopoietic stem cell fate.
Shokouhian M; Bagheri M; Poopak B; Chegeni R; Davari N; Saki N
J Cell Physiol; 2020 Oct; 235(10):6404-6423. PubMed ID: 32052445
[TBL] [Abstract][Full Text] [Related]
47. 'Traffic light rules': Chromatin states direct miRNA-mediated network motifs running by integrating epigenome and regulatome.
Zhao H; Zhang G; Pang L; Lan Y; Wang L; Yu F; Hu J; Li F; Zhao T; Xiao Y; Li X
Biochim Biophys Acta; 2016 Jul; 1860(7):1475-88. PubMed ID: 27091612
[TBL] [Abstract][Full Text] [Related]
48. Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models.
Vecchio E; Fiume G; Correnti S; Romano S; Iaccino E; Mimmi S; Maisano D; Nisticò N; Quinto I
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32549409
[TBL] [Abstract][Full Text] [Related]
49. Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level.
Chung C
J Oncol Pharm Pract; 2020 Jun; 26(4):943-966. PubMed ID: 31964218
[TBL] [Abstract][Full Text] [Related]
50. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
[TBL] [Abstract][Full Text] [Related]
51. Frequent mutation of the 5' noncoding region of the BCL-6 gene in acquired immunodeficiency syndrome-related non-Hodgkin's lymphomas.
Gaidano G; Carbone A; Pastore C; Capello D; Migliazza A; Gloghini A; Roncella S; Ferrarini M; Saglio G; Dalla-Favera R
Blood; 1997 May; 89(10):3755-62. PubMed ID: 9160681
[TBL] [Abstract][Full Text] [Related]
52. A model for spontaneous B-lineage lymphomas in IgHmu-HOX11 transgenic mice.
Hough MR; Reis MD; Singaraja R; Bryce DM; Kamel-Reid S; Dardick I; Breitman ML; Dubé ID
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13853-8. PubMed ID: 9811890
[TBL] [Abstract][Full Text] [Related]
53. ETO protein of t(8;21) AML is a corepressor for Bcl-6 B-cell lymphoma oncoprotein.
Chevallier N; Corcoran CM; Lennon C; Hyjek E; Chadburn A; Bardwell VJ; Licht JD; Melnick A
Blood; 2004 Feb; 103(4):1454-63. PubMed ID: 14551142
[TBL] [Abstract][Full Text] [Related]
54. Targeting EZH2 and PRC2 dependence as novel anticancer therapy.
Xu B; Konze KD; Jin J; Wang GG
Exp Hematol; 2015 Aug; 43(8):698-712. PubMed ID: 26027790
[TBL] [Abstract][Full Text] [Related]
55. B-Lymphoma cells with epigenetic silencing of Pax5 trans-differentiate into macrophages, but not other hematopoietic lineages.
Hodawadekar S; Yu D; Cozma D; Freedman B; Sunyer O; Atchison ML; Thomas-Tikhonenko A
Exp Cell Res; 2007 Jan; 313(2):331-40. PubMed ID: 17098231
[TBL] [Abstract][Full Text] [Related]
56. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes.
Mosquera Orgueira A; Ferreiro Ferro R; Díaz Arias JÁ; Aliste Santos C; Antelo Rodríguez B; Bao Pérez L; Alonso Vence N; Bendaña López Á; Abuin Blanco A; Melero Valentín P; Peleteiro Raindo AR; Cid López M; Pérez Encinas MM; González Pérez MS; Fraga Rodríguez MF; Bello López JL
PLoS One; 2021; 16(5):e0248886. PubMed ID: 33945543
[TBL] [Abstract][Full Text] [Related]
57. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec H; Grzeschiczek A; Kowalski MB; Möröy T
EMBO J; 1994 Aug; 13(15):3487-95. PubMed ID: 8062825
[TBL] [Abstract][Full Text] [Related]
58. Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.
Gil VS; Bhagat G; Howell L; Zhang J; Kim CH; Stengel S; Vega F; Zelent A; Petrie K
Dis Model Mech; 2016 Dec; 9(12):1483-1495. PubMed ID: 27799148
[TBL] [Abstract][Full Text] [Related]
59. STAT5 represses BCL6 expression by binding to a regulatory region frequently mutated in lymphomas.
Walker SR; Nelson EA; Frank DA
Oncogene; 2007 Jan; 26(2):224-33. PubMed ID: 16819511
[TBL] [Abstract][Full Text] [Related]
60. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]